FEATURED COMPANIES
- Abbott Nutrition
- B Braun Melsungen Ag
- BASF SE
- Baxter International Inc.
- Claris Lifesciences Ltd.
- Fresenius Kabi Ag
Asia Pacific clinical nutrition market will grow by 8.27% annually with a total addressable market cap of $180.67 billion over 2020-2026 driven by increasing incidence of malnutrition, the rising prevalence of communicable and non-communicable chronic diseases amid COVID-19 pandemic.
Highlighted with 35 tables and 69 figures, this 129-page report “Asia Pacific Clinical Nutrition Market 2020-2026 by Substrate, Administration Route (Oral or Enteral, Parenteral), End User, Therapeutic Area, Healthcare Setting, Distribution Channel, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific clinical nutrition market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2026 with 2019 as the base year.
In-depth qualitative analyses include identification and investigation of the following aspects:
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific clinical nutrition market in every aspect of the classification from perspectives of Substrate, Administration Route, End User, Therapeutic Area, Healthcare Setting, Distribution Channel, and Country.
Based on Substrate, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
Based on Administration Route, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
Oral or Enteral Administration
Parenteral Administration
Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
Based on Therapeutic Area, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
Based on Healthcare Setting, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
Based on Distribution Channel, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
Geographically, the following national/local markets are fully investigated:
For each country, detailed analysis and data for annual revenue are available for 2019-2026. The breakdown of key national markets by Administration Route, End User, and Therapeutic Area over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in Asia Pacific clinical nutrition market are assayed quantitatively and qualitatively through a Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
(Please Note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Highlighted with 35 tables and 69 figures, this 129-page report “Asia Pacific Clinical Nutrition Market 2020-2026 by Substrate, Administration Route (Oral or Enteral, Parenteral), End User, Therapeutic Area, Healthcare Setting, Distribution Channel, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific clinical nutrition market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2026 with 2019 as the base year.
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter’s Five Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific clinical nutrition market in every aspect of the classification from perspectives of Substrate, Administration Route, End User, Therapeutic Area, Healthcare Setting, Distribution Channel, and Country.
Based on Substrate, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
- Carbohydrates
- Lipids
- Proteins & Amino Acids
- Water & Electrolyte
- Dietary Fiber
- Antioxidants
- Other Substrates
Based on Administration Route, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
Oral or Enteral Administration
- Oral Nutrition Supplements
- Tube Feeding
Parenteral Administration
- Supplemental Parenteral Nutrition
- Total Parenteral Nutrition
- All-in-One System
- Multiple Bottle System
Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
- Infant
- Children
- Adult
- Geriatrics
Based on Therapeutic Area, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
- Malnutrition
- Metabolic Disorders
- Gastrointestinal Disorders
- Cancer
- Neurology
- Renal Diseases
- Respiratory Diseases
- Other Therapeutic Areas
Based on Healthcare Setting, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
- Hospitals
- Long-term Care Facilities (LTC)
- Homecare
- Inpatient Rehabilitation Facilities
- Other Healthcare Settings
Based on Distribution Channel, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
- Institutional Sales
- Supermarkets & Hypermarkets
- Pharmacies
- Drug Stores
- Online Channels
- Other Distribution Channels
Geographically, the following national/local markets are fully investigated:
- Japan
- China
- South Korea
- Australia
- India
- Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
For each country, detailed analysis and data for annual revenue are available for 2019-2026. The breakdown of key national markets by Administration Route, End User, and Therapeutic Area over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in Asia Pacific clinical nutrition market are assayed quantitatively and qualitatively through a Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
- Abbott Nutrition
- B Braun Melsungen Ag
- BASF SE
- Baxter International Inc.
- Claris Lifesciences Ltd.
- Fresenius Kabi Ag
- Lonza Group AG
- Nestle Health Science
- Nutricia Ltd
- Perrigo Company Plc
(Please Note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Abbott Nutrition
- B Braun Melsungen Ag
- BASF SE
- Baxter International Inc.
- Claris Lifesciences Ltd.
- Fresenius Kabi Ag
1 Introduction
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 Market Overview and Dynamics
3 Segmentation of Asia Pacific Market by Substrate
4 Segmentation of Asia Pacific Market by Administration Route
5 Segmentation of Asia Pacific Market by End User
6 Segmentation of Asia Pacific Market by Therapeutic Area
7 Segmentation of Asia Pacific Market by Healthcare Setting
8 Segmentation of Asia Pacific Market by Distribution Channel
9 Asia-Pacific Market 2019-2026 by Country
10 Competitive Landscape
11 Investing in Asia Pacific Market: Risk Assessment and Management
List of Tables
List of Figures
Note: Product cover images may vary from those shown
- Abbott Nutrition
- B Braun Melsungen Ag
- BASF SE
- Baxter International Inc.
- Claris Lifesciences Ltd.
- Fresenius Kabi Ag
- Lonza Group AG
- Nestle Health Science
- Nutricia Ltd
- Perrigo Company Plc
Note: Product cover images may vary from those shown
LOADING...
